Watson Pharmaceuticals Inc. (WPI) posted third quarter net income of $63.0 million, or $0.55 per diluted share, compared to $71.1 million or $0.62 per share in the prior year quarter.
Excluding special items, adjusted net income for the quarter was $76.1 million or $0.66 per share, compared to $54.0 million or $0.47 per share in last year quarter.
On average, 15 analysts polled by Thomson Reuters expected the company to report earnings of $0.65 per share. Analysts' estimates typically exclude special items.
Net revenue for the quarter was $662.1 million, compared to $640.7 million last year. Fourteen Wall Street analysts expected revenues of $688.53 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.